Krishnan, V., Schmidt, F., Nawaz, Z., Lee, K. L., Nori Venkatesh, P., Makheja, M., … Ong, S. T. (2022). A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia. In Blood (Vol. 140, pp. 792–794). American Society of Hematology. https://doi.org/10.1182/blood-2022-165758

Krishnan, Vaidehi, Florian Schmidt, Zahid Nawaz, Kian Leong Lee, Prasanna Nori Venkatesh, Meera Makheja, Zhu En Chan, et al. “A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia.” In Blood, 140:792–94. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-165758.

Krishnan V, Schmidt F, Nawaz Z, Lee KL, Nori Venkatesh P, Makheja M, et al. A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia. In: Blood. American Society of Hematology; 2022. p. 792–4.

Krishnan, Vaidehi, et al. “A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 792–94. Crossref, doi:10.1182/blood-2022-165758.

Krishnan V, Schmidt F, Nawaz Z, Lee KL, Nori Venkatesh P, Makheja M, Chan ZE, Yu M, Arul Rayan N, Gek Liang Lim M, Cheung A, Bari S, Ouyang J, Rackham O, Tan TZ, Hwang WYK, Chuah C, Prabhakar S, Ong ST. A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia. Blood. American Society of Hematology; 2022. p. 792–794.